EISAI LIMITED: CDA-AMC RECOGNIZES CLINICAL VALUE OF LEQEMBI & RECOMMENDS PUBLIC COVERAGE FOR EARLY ALZHEIMER'S DISEASE

Reuters · 2d ago

Please log in to view news